Searched for
CONCORD BIOTECH IPO DATES
Retail investors build big dreams on small slices of SpaceXSpaceX's initial public offering saw massive retail investor interest. A substantial 30% of shares were set aside for individual buyers. Ma...- SpaceX IPO date, price, valuation, stock symbol, how to buy shares: What US investors need to know about Elon Musk's historic listingThe SpaceX IPO date is Friday, June 12, with shares trading on Nasdaq under ticker SPCX at $135 per share. SpaceX's $1.77 trillion IPO aims...
- Two Trades for Today: A maker of forged components for a 7.7% gain, a mid-cap pharma stock for a 6% upmoveOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- SpaceX IPO: Know date, price, valuation, how to buy and other important detailsSpaceX is preparing for a massive IPO. The rocket and satellite company plans to raise $75 billion at a $1.75 trillion valuation. Shares ar...
- SpaceX IPO: Listing date, valuation among 10 things to know about the biggest stock market debut everElon Musk’s SpaceX is poised for a historic IPO, aiming to raise $75 billion at a $1.75 trillion valuation. Investor demand is strong, with...
- SpaceX IPO: Will Elon Musk become the world's first trillionaire after mega listing? The math is delicately poisedElon Musk SpaceX IPO: Elon Musk is on the cusp of becoming the world's first trillionaire as SpaceX prepares for its massive $75 billion IP...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian equities lost momentum after a positive start, with Nifty closing lower and broader markets declining sharply. Investor caution ahea...
- Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tabletsConcord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian equities ended higher on Tuesday, supported by easing geopolitical tensions and softer crude prices. A sharp drop in India VIX boost...
- Customers will feast as Zepto to pour fuel into quick commerce fireZepto’s proposed Rs 9,500 cr ($1 billion) IPO could significantly intensify competition in India’s already crowded quick commerce market. T...
- Zepto IPO: 8 things to know about quick commerce giant's Rs 9,500-crore public offerZepto’s Rs 9,500 crore IPO, comprising a fresh issue and offer for sale, is set to attract strong investor interest as the first standalone...
- GSK in talks to buy cancer biotech Nuvalent for more than $9 billionBritish drug giant GSK is reportedly in talks to acquire cancer drugmaker Nuvalent. The deal could be worth over nine billion dollars. Disc...
- Perplexity plans 2028 IPO regardless of Anthropic or OpenAI listings: ReportAI firm Perplexity plans to go public in 2028, irrespective of how Anthropic and OpenAI's IPOs perform. CEO Aravind Srinivas stated the 202...
- Perplexity plans 2028 IPO regardless of Anthropic or OpenAI listings, CNBC reportsOpenAI confidentially filed for a U.S. IPO earlier on Monday, following Anthropic's filing last week. Elon Musk's SpaceX is also preparing ...
- Carlsberg gears up to file for $700 million India IPOCarlsberg A/S is preparing to file draft papers for an IPO of its India unit as early as this month, sources said. The listing could raise ...
- Vahh Chemicals IPO: Check GMP, price band, subscription and other detailsVahh Chemicals' Initial Public Offering opens for subscription on Thursday. Grey market indicators suggest robust investor interest. The co...
- Concord Biotech shares jump 8% on USFDA nod for Mycophenolate Mofetil oral suspensionConcord Biotech shares saw a significant jump on Wednesday. This surge followed the company's announcement of receiving approval from the U...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian benchmark indices ended higher after a volatile session, with late buying in heavyweight IT stocks lifting sentiment. Sensex gained ...
- Oyo-parent Prism secures Sebi's nod to launch Rs 6,650-crore IPOOyo's parent company, Prism, has received approval from Sebi to proceed with its Rs 6,650 crore IPO. The company is expected to be valued b...
- Q-Line Biotec shares to list today. Check GMP ahead of debutQ-Line Biotech is poised for a strong stock market debut on Friday. Investor demand appears robust, with grey market trends showing a signi...
Load More
